The Congress on Controversies in Ophthalmology will be held April 4-5 in Seville, Spain.As the name implies, the unique ...

The Global Vial Adaptors for Reconstitution Drug Market is poised for substantial growth, reflecting strong financial projections and industry expansion. In 2023, the market was valued at USD 2,186.69 ...

Biomedical engineers at Duke University have demonstrated a promising new approach that could be used to treat a rare and ...

Delivering drugs to specific, hard-to-reach areas in the human body remains a challenge in drug development. Typically, drug molecules administered via pills or injections circulate randomly through ...

A research team, affiliated with UNIST has unveiled soft self-standing protein hydrogels that selectively deliver drugs, ...

Compelling Patient Response Highlighted by Stable Disease and Significant Reduction in Blast Count After One Treatment Cycle HOUSTON, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ ...

Kuick Research Report Highlights Ongoing Developments In Molecular Switches Application Therapeutic Targets & Drug Delivery ...

PureTech Founded Entity Seaport Therapeutics Announces Publication of New Research Demonstrating Increased Lymphatic Transport with Glyph Platform ...

Molecular communications in the bloodstream is a promising area of research, since the bloodstream has the ability to ...

Seaport Therapeutics (“Seaport” or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced the ...

Royalty Pharma to provide R&D investment of up to $250 million for Biogen's litifilimab, a potential first-in-class biologic in Phase 3 development for the treatment of lupus. NEW ...

The breakthrough in drug delivery hinges on the development of nanoarchaeosomes, which are nanoparticles loaded with ...